Navigation Links
'Off-Label' Drug Use Appears Common
Date:4/16/2012

MONDAY, April 16 (HealthDay News) -- Off-label prescribing of medications is common, but the practice varies according to drug, and patient and doctor characteristics, a Canadian study finds.

In off-label prescribing, a doctor prescribes drugs for uses that have not been approved by regulators. For example, some medicines approved to treat depression are also prescribed for chronic pain.

The practice, which is legal but unregulated, is believed to contribute to preventable medication-related harm in patients, according to Dr. Tewodros Eguale, of McGill University in Montreal, and colleagues.

For the study, they examined more than 250,000 electronic prescriptions for more than 50,000 patients written from 2005 through 2009 by 113 doctors in a primary care network in Canada.

The study results were released online in advance of print publication in the journal Archives of Internal Medicine as part of the journal's health-care reform series.

About 11 percent of the medications were prescribed for off-label use, and 79 percent of off-label use lacked strong scientific evidence, the researchers found. The amount of off-label use in this study was less than in a previous U.S. study, the authors noted in a journal news release.

The investigators found that the highest rate of off-label use involved central nervous system drugs (26 percent), anti-infective agents (17 percent), and ear-nose-throat medications (15 percent). The study also found that drugs with three or four approved uses were less likely to be prescribed off-label than those with one or two approved uses.

Medications approved after 1995 were less likely to be prescribed off-label than those approved before 1981, and doctors with high scores on evidence-based practice were less likely to prescribe off-label, the findings showed.

"Our findings indicate that off-label prescribing is common in primary care and varies by drug class, the number of approved indications for the drug, the age of the drug, patients' sex and physicians' attitude toward evidence-based medicine," the researchers concluded.

"Electronic health records can be used to document treatment indication at the time of prescribing and may pave the way for enhanced post-marketing evaluation of drugs if linked to treatment outcomes," Eguale and colleagues wrote.

More information

The U.S. Agency for Healthcare Research and Quality has more about off-label prescribing.

-- Robert Preidt

SOURCE: Archives of Internal Medicine, news release, April 16, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hemophilia Drug Used Off-Label Raises Clot Risk
2. Off-Label Use of Clotting Drug Soars, Report Finds
3. Mixed Results Seen With Off-Label Use of Antipsychotics
4. Protein Appears Key to Intestinal Balance
5. How health care is paid for appears to impact outcome
6. Hospitalization Appears to Help Personality Disorder Patients
7. Taking Flu Drugs While Pregnant Appears to Be Safe: Study
8. NAMI Medical Director Honored with APA Patient Advocacy Award; Appears in CNN Health and Huffington Post Columns
9. Celebrex Appears Easier on Stomach for Arthritis Patients
10. Plasma protein appears to be associated with development and severity of Alzheimers disease
11. FDA Panel Appears Skeptical Over Key Avandia Data
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Off-Label' Drug Use Appears Common
(Date:3/29/2017)... ... ... Grass pollen is the main cause of hay fever in the United States, with an ... runs from May to July each year; with the worst time for sufferers being June ... balms ( http://www.haymax.us ) provide an effective defense against grass pollen; they are proven in ...
(Date:3/29/2017)... ... March 30, 2017 , ... Youth Futures International (YFI) premiered its ... from high school and college students who have participated in the program every summer. ... YFI is now accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to learn ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sports Brand EXOUS Bodygear announced today ... normally at $29.97; for the remaining days of March, the price will be only ... a special price of just $10 (regular retail price $19.97). , The special promotional ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, ... Stores in two southeastern states. Ingredients in HeartBoost, an over the counter heart ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based ... into the challenges employers face in trying to balance both short-term and long-term ... programs? Adding to the growing complexity, companies are finding that the short-term ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... -- Research and Markets has announced the addition ... report to their offering. ... The global orthopedic navigation system ... Increasing geriatric population prone to orthopedic diseases is a key ... the forecast period. Osteoarthritis and osteoporosis are most common disorders ...
(Date:3/29/2017)... Mar 29, 2017  Providence Medical Technology, Inc., ... addition of two industry veterans to the commercial ... the company to lead Global Marketing, and ... Mr. Lynch and Mr. Scott have over 40 ... Mr. Lynch joins the company with over 22 ...
(Date:3/29/2017)... 29, 2017  The leader in accelerated orthodontics, OrthoAccel ... Sam Daher , Manal Ibrahim , Kenji ... will be the featured microlecture presenters at the AcceleDent ... of Orthodontists (AAO) Annual Session, April 21-25, 2017. Orthodontists ... beginning daily at 11:20 a.m. On the opening morning ...
Breaking Medicine Technology: